NPI: 1447212592 · MIDLOTHIAN, VA 23114 · General Acute Care Hospital · NPI assigned 04/04/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 81,829 | $2.18M |
| 2019 | 110,906 | $3.22M |
| 2020 | 90,381 | $3.19M |
| 2021 | 116,447 | $4.24M |
| 2022 | 167,321 | $7.07M |
| 2023 | 238,172 | $12.19M |
| 2024 | 215,818 | $12.78M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 49,066 | 43,393 | $8.42M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 35,776 | 30,918 | $6.50M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21,489 | 18,400 | $3.89M |
| 96361 | Intravenous infusion, hydration; each additional hour | 11,363 | 9,034 | $3.34M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 35,006 | 25,184 | $3.09M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8,891 | 7,863 | $2.11M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11,849 | 10,562 | $1.73M |
| 70450 | Computed tomography, head or brain; without contrast material | 8,103 | 7,090 | $1.40M |
| G0378 | Hospital observation service, per hour | 6,140 | 3,769 | $847K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,844 | 1,612 | $807K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,993 | 3,491 | $781K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,389 | 2,146 | $633K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,823 | 1,686 | $598K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 748 | 665 | $486K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,501 | 3,056 | $448K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6,202 | 5,688 | $405K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 9,974 | 3,265 | $383K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,524 | 933 | $367K |
| 59025 | Fetal non-stress test | 2,175 | 1,676 | $338K |
| 41899 | Unlisted procedure, dentoalveolar structures | 242 | 222 | $337K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,025 | 916 | $336K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,803 | 1,669 | $305K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,882 | 903 | $280K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 396 | 362 | $280K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,729 | 1,279 | $269K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,339 | 2,804 | $260K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,687 | 2,414 | $236K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,784 | 1,620 | $229K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 3,464 | 3,073 | $212K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4,372 | 4,132 | $206K |
| 93971 | 2,301 | 2,013 | $200K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,014 | 907 | $196K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,814 | 3,314 | $194K |
| 97162 | 1,483 | 1,356 | $187K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,327 | 2,645 | $187K |
| 70496 | 631 | 568 | $173K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,083 | 999 | $164K |
| 76819 | Fetal biophysical profile; without non-stress testing | 2,120 | 1,157 | $156K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 740 | 678 | $151K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,387 | 1,229 | $130K |
| 72141 | 806 | 733 | $129K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 172 | 152 | $120K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 891 | 845 | $117K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,313 | 4,096 | $113K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1,285 | 1,187 | $110K |
| 80053 | Comprehensive metabolic panel | 43,040 | 34,818 | $110K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 4,176 | 1,631 | $109K |
| 97161 | 1,470 | 1,283 | $107K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 5,146 | 1,908 | $101K |
| 76830 | Ultrasound, transvaginal | 1,508 | 1,337 | $96K |
| 71046 | Radiologic examination, chest; 2 views | 15,708 | 13,878 | $91K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 198 | 177 | $88K |
| 70491 | 299 | 276 | $85K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 558 | 520 | $83K |
| 76536 | 729 | 684 | $78K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,661 | 1,428 | $77K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 462 | 445 | $70K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,647 | 1,475 | $64K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 582 | 549 | $62K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,500 | 1,340 | $59K |
| 93970 | 431 | 387 | $55K | |
| 11043 | 261 | 113 | $53K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24,035 | 20,006 | $53K |
| 90791 | Psychiatric diagnostic evaluation | 254 | 230 | $52K |
| 71250 | 878 | 791 | $51K | |
| 76642 | 487 | 415 | $50K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 314 | 298 | $47K |
| 12001 | 234 | 218 | $43K | |
| 76801 | 1,225 | 1,089 | $41K | |
| 97535 | Self-care/home management training, each 15 minutes | 1,509 | 1,107 | $40K |
| 90677 | 951 | 845 | $40K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,677 | 1,604 | $40K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,270 | 684 | $37K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,927 | 6,973 | $34K |
| 72100 | 2,516 | 2,264 | $34K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 398 | 373 | $34K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 275 | 246 | $32K |
| 71271 | 311 | 292 | $30K | |
| 97116 | 1,093 | 657 | $28K | |
| 97014 | 729 | 253 | $27K | |
| G0379 | Direct admission of patient for hospital observation care | 197 | 169 | $26K |
| 97165 | 615 | 529 | $24K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 174 | 161 | $23K |
| 83880 | 3,697 | 3,051 | $22K | |
| 76818 | 300 | 155 | $21K | |
| 73562 | 3,110 | 2,562 | $21K | |
| 73221 | 98 | 91 | $21K | |
| 72131 | 380 | 344 | $21K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 155 | 134 | $20K |
| 73630 | 2,650 | 2,264 | $20K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4,068 | 3,680 | $19K |
| 90715 | 1,012 | 932 | $19K | |
| 70498 | 658 | 592 | $18K | |
| 87040 | 3,385 | 1,792 | $17K | |
| 74018 | 2,111 | 1,908 | $17K | |
| 90714 | 709 | 667 | $16K | |
| 85379 | 4,073 | 3,636 | $15K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,590 | 2,340 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 49,249 | 38,909 | $15K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 19,071 | 15,920 | $15K |
| 73030 | 1,904 | 1,669 | $14K | |
| 84484 | 17,729 | 12,504 | $14K | |
| 70486 | 318 | 288 | $14K | |
| 74183 | 42 | 37 | $13K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 24,190 | 20,365 | $12K |
| 76770 | 88 | 81 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3,655 | 3,473 | $12K |
| 76820 | 300 | 150 | $12K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 22,151 | 17,456 | $11K |
| J3490 | Unclassified drugs | 9,525 | 4,769 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 12,302 | 9,121 | $11K |
| 81025 | 16,800 | 14,578 | $11K | |
| 36415 | Collection of venous blood by venipuncture | 55,045 | 41,416 | $10K |
| 73130 | 1,717 | 1,470 | $10K | |
| G0008 | Administration of influenza virus vaccine | 1,883 | 1,659 | $10K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 508 | 439 | $10K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 98 | 86 | $9K |
| 90674 | 412 | 376 | $9K | |
| 90661 | 469 | 462 | $9K | |
| 73610 | 2,381 | 2,109 | $8K | |
| 90746 | 186 | 182 | $8K | |
| 99218 | 926 | 456 | $8K | |
| 82962 | 12,372 | 5,661 | $7K | |
| 72050 | 281 | 262 | $7K | |
| 71045 | Radiologic examination, chest; single view | 8,683 | 7,433 | $7K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 341 | 286 | $7K |
| 81001 | 29,816 | 25,494 | $7K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15,416 | 13,374 | $7K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 18,188 | 14,258 | $7K |
| G0010 | Administration of hepatitis b vaccine | 351 | 332 | $7K |
| 73502 | 1,020 | 880 | $7K | |
| 99381 | 53 | 40 | $6K | |
| 86850 | 2,780 | 2,432 | $6K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,983 | 3,307 | $6K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 260 | 245 | $6K |
| 90647 | 784 | 669 | $6K | |
| 10060 | 44 | 41 | $5K | |
| 77080 | 106 | 96 | $5K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 184 | 151 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | 15,478 | 12,312 | $5K |
| 76870 | 49 | 44 | $5K | |
| 86900 | 3,554 | 3,152 | $5K | |
| 84145 | 900 | 760 | $4K | |
| 83605 | 3,823 | 3,037 | $4K | |
| 77065 | Tomosynthesis, mammo | 116 | 96 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,973 | 2,487 | $4K |
| 90723 | 622 | 519 | $4K | |
| 12011 | 28 | 27 | $4K | |
| 90681 | 579 | 489 | $4K | |
| 90651 | 265 | 253 | $4K | |
| 90716 | 289 | 263 | $4K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,904 | 3,050 | $4K |
| 90633 | 577 | 528 | $4K | |
| 80050 | General health panel | 738 | 681 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4,521 | 3,736 | $3K |
| 73700 | 44 | 40 | $3K | |
| 90686 | 682 | 582 | $3K | |
| 85027 | 2,930 | 2,286 | $3K | |
| 77066 | Tomosynthesis, mammo | 69 | 67 | $3K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 384 | 318 | $3K |
| 96376 | 5,216 | 3,031 | $3K | |
| 10061 | 13 | 13 | $3K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 8,484 | 6,029 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,624 | 5,691 | $3K |
| J1644 | Injection, heparin sodium, per 1000 units | 1,117 | 535 | $3K |
| 85610 | 4,588 | 3,478 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1,797 | 1,602 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,721 | 6,478 | $2K |
| 86901 | 3,552 | 3,150 | $2K | |
| 83735 | 10,623 | 8,253 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6,396 | 5,858 | $2K |
| 90670 | 289 | 253 | $2K | |
| 85730 | 1,868 | 1,596 | $2K | |
| G0009 | Administration of pneumococcal vaccine | 1,337 | 1,184 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,584 | 5,382 | $2K |
| 73110 | 999 | 884 | $2K | |
| 80047 | 367 | 312 | $2K | |
| 90707 | 259 | 240 | $2K | |
| 99385 | 15 | 14 | $2K | |
| 97016 | 54 | 26 | $2K | |
| 85018 | 753 | 594 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 7,878 | 6,395 | $2K |
| 73080 | 446 | 405 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,140 | 2,985 | $2K |
| 74240 | 14 | 13 | $2K | |
| 87070 | 6,255 | 5,643 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 5,859 | 3,503 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,364 | 6,237 | $2K |
| 90734 | 223 | 217 | $2K | |
| 99152 | 932 | 785 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,830 | 1,323 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | 4,831 | 3,790 | $2K |
| 99383 | 12 | 12 | $1K | |
| 90698 | 235 | 221 | $1K | |
| 81003 | 2,309 | 1,890 | $1K | |
| 88307 | 172 | 134 | $1K | |
| 86140 | 1,847 | 1,605 | $1K | |
| 83690 | 15,356 | 12,989 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,553 | 2,307 | $1K |
| 80143 | 766 | 690 | $1K | |
| J2704 | Injection, propofol, 10 mg | 12,172 | 8,375 | $1K |
| 80179 | 700 | 631 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,544 | 2,604 | $1K |
| 84703 | 1,068 | 974 | $967.38 | |
| 80061 | Lipid panel | 510 | 448 | $903.11 |
| 73590 | 291 | 254 | $857.87 | |
| 90700 | 130 | 124 | $848.67 | |
| 87210 | 2,098 | 1,751 | $818.69 | |
| 87634 | 537 | 509 | $775.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,301 | 2,571 | $710.84 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,769 | 1,385 | $705.36 |
| 77062 | 24 | 24 | $664.56 | |
| 90710 | 87 | 85 | $654.46 | |
| 87077 | 2,397 | 2,017 | $623.77 | |
| 99406 | 35 | 33 | $579.29 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 63 | 52 | $557.74 |
| 73140 | 293 | 273 | $535.88 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 79 | 69 | $527.85 |
| 72072 | 59 | 50 | $495.44 | |
| 84100 | 1,960 | 1,358 | $471.31 | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,261 | 1,101 | $442.61 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,388 | 1,922 | $436.70 |
| 74019 | 110 | 96 | $402.45 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 18 | 15 | $387.46 |
| 87186 | 2,190 | 1,872 | $369.62 | |
| 90694 | 55 | 46 | $362.91 | |
| 84702 | 2,344 | 2,032 | $361.76 | |
| 80305 | 57 | 55 | $352.20 | |
| 82077 | 2,295 | 1,976 | $349.03 | |
| 87205 | 354 | 286 | $343.29 | |
| J2060 | Injection, lorazepam, 2 mg | 707 | 553 | $337.67 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,889 | 1,554 | $312.62 |
| 71101 | 121 | 112 | $311.16 | |
| 85652 | 1,077 | 947 | $295.68 | |
| 94761 | 2,870 | 1,661 | $294.82 | |
| 99153 | Mod sedat endo service >5yrs | 224 | 188 | $288.05 |
| 90696 | 37 | 37 | $281.22 | |
| 80076 | 89 | 73 | $264.65 | |
| C1776 | Joint device (implantable) | 15 | 13 | $258.95 |
| 98960 | 100 | 65 | $250.77 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 512 | 497 | $227.65 |
| 0100U | 18 | 16 | $226.40 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 571 | 448 | $221.04 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 2,565 | 2,112 | $200.54 |
| 73090 | 167 | 156 | $195.96 | |
| 82553 | 79 | 64 | $189.32 | |
| 90653 | 132 | 90 | $174.78 | |
| 94760 | 474 | 297 | $167.62 | |
| C9113 | Injection, pantoprazole sodium, per vial | 818 | 462 | $165.80 |
| 84112 | 14 | 12 | $162.93 | |
| 82565 | 151 | 134 | $156.81 | |
| 87807 | 600 | 565 | $134.05 | |
| 88304 | 303 | 263 | $122.64 | |
| 51701 | 18 | 16 | $109.55 | |
| 72040 | 43 | 40 | $109.39 | |
| 82550 | 1,500 | 1,215 | $109.35 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 698 | 556 | $104.23 |
| 29125 | 60 | 58 | $100.00 | |
| 87147 | 1,453 | 1,189 | $94.86 | |
| 82570 | 200 | 156 | $82.99 | |
| 73560 | 19 | 13 | $79.97 | |
| 90473 | 65 | 57 | $67.82 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 981 | 885 | $66.07 |
| 84156 | 99 | 79 | $63.51 | |
| 83615 | 50 | 41 | $60.07 | |
| 81002 | 254 | 229 | $57.89 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 934 | 766 | $54.46 |
| 82607 | 92 | 77 | $45.58 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 1,287 | 1,166 | $41.84 |
| J3480 | Injection, potassium chloride, per 2 meq | 514 | 277 | $41.75 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,060 | 915 | $41.19 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 738 | 579 | $38.95 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 770 | 613 | $34.49 |
| 94762 | 247 | 186 | $25.63 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 799 | 727 | $20.62 |
| 84439 | 77 | 66 | $18.58 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 285 | 247 | $16.91 |
| 83550 | 45 | 39 | $15.55 | |
| 87088 | 222 | 208 | $14.41 | |
| 83540 | 44 | 39 | $11.97 | |
| 82150 | 16 | 12 | $11.94 | |
| 82728 | 30 | 26 | $11.66 | |
| 82803 | 631 | 525 | $10.97 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 63 | 40 | $10.21 |
| 86580 | 63 | 26 | $9.30 | |
| 86308 | 43 | 40 | $6.55 | |
| A9270 | Non-covered item or service | 2,092 | 636 | $4.99 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 67 | 62 | $2.78 |
| 82272 | 85 | 75 | $2.70 | |
| J1790 | Injection, droperidol, up to 5 mg | 400 | 351 | $1.94 |
| J7510 | Prednisolone oral, per 5 mg | 14 | 13 | $1.17 |
| J3370 | Injection, vancomycin hcl, 500 mg | 413 | 183 | $0.98 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 387 | 292 | $0.34 |
| A4565 | Slings | 118 | 103 | $0.26 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 552 | 463 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 237 | 221 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 183 | 146 | $0.00 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 176 | 70 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 138 | 102 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 138 | 118 | $0.00 |
| 76937 | 13 | 13 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 14 | 12 | $0.00 |
| 96367 | 38 | 28 | $0.00 | |
| 82947 | 17 | 14 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 17 | 12 | $0.00 |
| 84295 | 15 | 12 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 343 | 271 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 63 | 48 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 72 | 66 | $0.00 |
| C1769 | Guide wire | 151 | 128 | $0.00 |
| 88342 | 146 | 113 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 790 | 733 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 113 | 60 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 91 | 74 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 72 | 37 | $0.00 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 52 | 52 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 218 | 64 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 108 | 106 | $0.00 |
| 84132 | 35 | 28 | $0.00 | |
| 82746 | 32 | 26 | $0.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 74 | 68 | $0.00 |
| 82330 | 48 | 43 | $0.00 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 13 | 13 | $0.00 |
| A4217 | Sterile water/saline, 500 ml | 16 | 14 | $0.00 |